Amir Torshizi Esfahani

Amir Torshizi Esfahani

Auto-generated profile, based on publicly available information

Amir Torshizi Esfahani

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences , Tehran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
AEAmir Torshizi Esfahani
Amir Torshizi Esfahani
SSSeyed Yoosef Seyedna
Seyed Yoosef Seyedna
ENEhsan Nazemalhosseini-Mojarad
Ehsan Nazemalhosseini-Mojarad
AMAhmad Majd
Ahmad Majd
HAHamid Asadzadeh Aghdaei
Hamid Asadzadeh Aghdaei

5 March 2025 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
AEAmir Torshizi Esfahani
Amir Torshizi Esfahani
NZNikta Zafarjafarzadeh
Nikta Zafarjafarzadeh
FVFatemeh Vakili
Fatemeh Vakili
ABAnahita Bizhanpour
Anahita Bizhanpour
AMAmirhesam Mashaollahi
Amirhesam Mashaollahi
SMSomayeh Mohammadpour
Somayeh Mohammadpour
Colorectal cancer (CRC) is a major global health challenge. Emerging research highlights the pivotal role of the gut microbiota in influencing CRC risk, progression, and treatment response. Metagenomic approaches, especially high-throughput shotgun sequencing, have provided unprecedented insights into the intricate connections between the gut microbiome and CRC. By enabling comprehensive taxonomic and functional profiling, metagenomics has revealed microbial signatures, activities, and biomarkers associated with colorectal tumorigenesis. Furthermore, metagenomics has shown a potential to guide patient stratification, predict treatment outcomes, and inform microbiome-targeted interventions. Despite remaining challenges in multi-omics data integration, taxonomic gaps, and validation across diverse cohorts, metagenomics has propelled our comprehension of the intricate gut microbiome-CRC interplay. This review underscores the clinical relevance of microbial signatures as potential diagnostic and prognostic tools in CRC. Furthermore, it discusses personalized treatment strategies guided by this omics’ approach.

1 May 2024 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
SMSomayeh Mohammadpour
Somayeh Mohammadpour
FNFatemeh Naderi Noukabadi
Fatemeh Naderi Noukabadi
AEAmir Torshizi Esfahani
Amir Torshizi Esfahani
FKFatemeh Kazemi
Fatemeh Kazemi
SESahar Esmaeili
Sahar Esmaeili
ENEhsan Nazemalhosseini-Mojarad
Ehsan Nazemalhosseini-Mojarad
Colorectal cancer (CRC) is one of the world's most common types of malignancy. The proliferation of precancerous lesions causes this type of cancer. Two distinct pathways for CRC carcinogenesis have been identified: the conventional adenoma-carcinoma pathway and the serrated neoplasia pathway. Recently, evidence has demonstrated the regulatory roles of noncoding RNAs (ncRNAs) in the initiation and progression of precancerous lesions, especially in the adenoma-carcinoma pathway and serrated neoplasia pathway. By expanding the science of molecular genetics and bioinformatics, several studies have identified dysregulated ncRNAs that function as oncogenes or tumor suppressors in cancer initiation and formation by diverse mechanisms via intracellular signaling pathways known to act on tumor cells. However, many of their roles are still unclear. This review summarizes the functions and mechanisms of ncRNAs (such as long non-coding RNAs, microRNAs, long intergenic non-coding RNAs, small interfering RNAs, and circRNAs) in the initiation and formation of precancerous lesions.

1 August 2020 in Biomarkers in Medicine
Verified
Journal Article
Closed access
RRReza Ranjbar
Reza Ranjbar
AEAmir T Esfahani
Amir T Esfahani
ENEhsan Nazemalhosseini-Mojarad
Ehsan Nazemalhosseini-Mojarad
MOMeysam Olfatifar
Meysam Olfatifar
HAHamid Asadzadeh Aghdaei
Hamid Asadzadeh Aghdaei
SMSomayeh Mohammadpour
Somayeh Mohammadpour
Aim: The prognostic and predictive value of Elevated Microsatellite Alterations at Selected Tetranucleotide (EMAST) has been reported in colorectal cancer (CRC). The prevalence of EMAST in CRC vari...